| Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory … European Recombinant Human LH Study Group J Clin Endocrinol Metab 83 (5), 1507-14, 1998 | 294 | 1998 |
| A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating … DW Warne, G Decosterd, H Okada, Y Yano, N Koide, CM Howles Fertility and sterility 92 (2), 594-604, 2009 | 155 | 2009 |
| A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI M Wikland, C Bergh, K Borg, T Hillensjö, CM Howles, A Knutsson, ... Human Reproduction 16 (8), 1676-1681, 2001 | 107 | 2001 |
| Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG L Maislisch, D Warne, S Bologna, E Loumaye Human Reproduction 15 (7), 1446-1451, 2000 | 94 | 2000 |
| Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a … The International Recombinant Human Chorionic Gonadotropin Study Group Fertility and Sterility 75 (6), 1111-1118, 2001 | 84 | 2001 |
| Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized … A Nyboe-Andersen, P Humaidan, G Fried, J Hausken, L Antila, ... Human reproduction 23 (2), 427-434, 2008 | 77 | 2008 |
| Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism P Bouloux, DW Warne, E Loumaye Fertility and sterility 77 (2), 270-273, 2002 | 75 | 2002 |
| Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic … JN Hugues, DH Barlow, Z Rosenwaks, I Cédrin-Durnerin, S Robson, ... Reproductive biomedicine online 6 (2), 185-190, 2003 | 74 | 2003 |
| Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism European Metrodin HP Study Group Fertil Steril 70 (2), 256-262, 1998 | 66 | 1998 |
| Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study JA Huirne, JN Hugues, C Pirard, F Fischl, JC Sage, JL Pouly, A Obruca, ... Human Reproduction 21 (6), 1408-1415, 2006 | 56 | 2006 |
| Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa F Olivennes, G Trew, A Borini, F Broekmans, P Arriagada, DW Warne, ... Reproductive BioMedicine Online, 2014 | 43 | 2014 |
| Lexical-phonological interactions in bilingual children MM Kehoe First Language 35 (2), 93-125, 2015 | 32 | 2015 |
| Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study TRFB Hans-Peter Hartung, ..., Hervé Porchet, Robert Glanzman, David Warne ... Multiple Sclerosis Journal, 2021 | 31* | 2021 |
| Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility CM Howles, V Alam, D Tredway, R Homburg, DW Warne Reproductive biomedicine online 20 (2), 182-190, 2010 | 22 | 2010 |
| Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins A Lass, A Vassiliev, G Decosterd, D Warne, E Loumaye Fertility and sterility 78 (2), 265-269, 2002 | 20 | 2002 |
| The role of adaptive trial designs in drug development SH Francois Curtin Expert Reviews of Clinical Pharmacology, 727-736, 2017 | 18 | 2017 |
| A comparison of 3-day and daily follicle-stimulating hormone injections on stimulation Days 1–6 in women undergoing controlled ovarian hyperstimulation MCW Scholtes, B Schnittert, D van Hoogstraten, HC Verhoeven, A Zrener, ... Fertility and sterility 81 (4), 996-1001, 2004 | 11 | 2004 |
| Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis. DW Warne, D Tredway, JC Schertz, S Schnieper-Samec, V Alam, ... The Journal of reproductive medicine 56 (1-2), 31, 2011 | 8 | 2011 |
| Recombinant follicle-stimulating hormone (follitropin alfa) versus purified urinary follicle-stimulating hormone in a low-dose step-up regimen to induce ovulation in Japanese … Y Taketani, E Kelly, Y Yoshimura, H Hoshiai, M Irahara, H Mizunuma, ... Reproductive medicine and biology 9 (2), 99-106, 2010 | 8 | 2010 |
| Addition of rLH (Luveris) to rFSH during the final days of follicular maturation in IVF/ICSI treated patients. A Nordic randomized multicenter trial AN Andersen, P Humaidan, G Fried Human Reproduction 21, I54-I54, 2006 | 8 | 2006 |
Colin M HowlesFounder & EVP Scientific Affairs ARIES Consulting and Honorary Fellow, Univ EdinburghVerified email at ariesconsulting.ch
